Pyrogen Testing Market by Product & Service (Assays, Kits, Reagents, Instruments, Services), Test Type (LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User (Pharmaceutical, Biotechnology, Medical Device), Region - Global Forecast to 2025
The global pyrogen testing market size is projected to reach USD 1,689 million by 2025 from USD 927 million in 2020, at a CAGR of 12.7% during the forecast period. Market growth is driven by factors such as the rising incidence of infectious diseases and increasing pandemics frequency, increasing R & D in the pharmaceutical and biotechnology industries, growing focus on personalized medicine, and the rising prevalence of chronic diseases. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years.
“The assays, kits, & reagents accounted for the highest growth rate in the pyrogen testing market, by product & service, during the forecast period”
The pyrogen testing market is segmented into assays, kits, & reagents, instruments, and services based on product & service. The assays, kits, & reagents segment accounted for the highest growth rate in the pyrogen testing market in 2019. The requirement of assays, kits, & reagents in large numbers compared to instruments is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of assays, kits, & reagents compared to instruments and the rising preference for kit-based testing.
“LAL tests segment accounted for the highest CAGR”
Based on the test type, the pyrogen testing market is segmented into LAL tests, in vitro tests, and rabbit tests. The LAL tests segment is further categorized into chromogenic tests, turbidimetric tests, and gel clot tests. In 2019, the LAL tests segment accounted for the highest growth rate. The rising need for innovative laboratory testing procedures, increasing health standards, growing drug pipelines, and the increasing support for vaccine development are the major factors driving this segment's growth.
“Pharmaceutical & biotechnology companies segment accounted for the highest CAGR”
Based on end-users, the pyrogen testing market is segmented into pharmaceutical & biotechnology companies, medical device companies, and other end users. In 2019, the pharmaceutical & biotechnology companies segment accounted for the highest growth rate. This can be attributed to many ongoing drug discovery activities and the increasing number of R&D facilities globally.
“Asia Pacific: The fastest-growing region pyrogen testing market”
The global pyrogen testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the expansion by key market players in emerging Asian countries and the increasing trend of pharmaceutical outsourcing to Asian countries like India and China are driving the growth of the pyrogen testing market in this region.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the global pyrogen testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, test type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pyrogen testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.
“The assays, kits, & reagents accounted for the highest growth rate in the pyrogen testing market, by product & service, during the forecast period”
The pyrogen testing market is segmented into assays, kits, & reagents, instruments, and services based on product & service. The assays, kits, & reagents segment accounted for the highest growth rate in the pyrogen testing market in 2019. The requirement of assays, kits, & reagents in large numbers compared to instruments is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of assays, kits, & reagents compared to instruments and the rising preference for kit-based testing.
“LAL tests segment accounted for the highest CAGR”
Based on the test type, the pyrogen testing market is segmented into LAL tests, in vitro tests, and rabbit tests. The LAL tests segment is further categorized into chromogenic tests, turbidimetric tests, and gel clot tests. In 2019, the LAL tests segment accounted for the highest growth rate. The rising need for innovative laboratory testing procedures, increasing health standards, growing drug pipelines, and the increasing support for vaccine development are the major factors driving this segment's growth.
“Pharmaceutical & biotechnology companies segment accounted for the highest CAGR”
Based on end-users, the pyrogen testing market is segmented into pharmaceutical & biotechnology companies, medical device companies, and other end users. In 2019, the pharmaceutical & biotechnology companies segment accounted for the highest growth rate. This can be attributed to many ongoing drug discovery activities and the increasing number of R&D facilities globally.
“Asia Pacific: The fastest-growing region pyrogen testing market”
The global pyrogen testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the expansion by key market players in emerging Asian countries and the increasing trend of pharmaceutical outsourcing to Asian countries like India and China are driving the growth of the pyrogen testing market in this region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6% , and the Middle East & Africa – 4%
- Charles River Laboratories, Inc. (US)
- Lonza (Switzerland)
- Merck KGaA (Germany)
- Thermo Fisher Scientific, Inc. (US)
- Associates of Cape Cod, Inc. (US)
- GenScript Biotech Corporation (China)
- bioM?rieux SA (France)
- FUJIFILM Wako Pure Chemical Corporation (Japan)
- Eurofins Scientific (Luxembourg)
- WuXi AppTec (China)
- Hycult Biotech (Netherlands)
- Ellab A/S (Denmark)
- Microcoat Biotechnologie GmbH (Germany)
- InvivoGen (US)
- Nelson Laboratories, LLC (US)
- Almac Group (UK)
- Pacific Biolabs (US)
- STERIS plc (US)
- Accugen Laboratories, Inc. (US)
- TOXIKON (US)
- Minerva Analytix GmbH (Germany)
- Indoor Biotechnologies, Inc. (US)
- Creative Bioarray (US)
- Lucideon Limited (UK)
- North American Science Associates, Inc. (US)
This report provides a detailed picture of the global pyrogen testing market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, test type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pyrogen testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 PYROGEN TESTING MARKET
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 LIMITATIONS OF THE CURRENT EDITION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 PYROGEN TESTING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2.2.1 Key data from primary sources
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 PYROGEN TESTING MARKET: BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
FIGURE 5 PYROGEN TESTING MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 PYROGEN TESTING MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 PYROGEN TESTING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 PYROGEN TESTING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 PYROGEN TESTING MARKET OVERVIEW
FIGURE 11 INCREASING R&D IN THE PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES IS DRIVING THE GROWTH OF THE PYROGEN TESTING MARKET
4.2 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 ASSAYS, KITS, & REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
4.3 PYROGEN TESTING MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST
END USERS OF PYROGEN TESTING PRODUCTS & SERVICES
4.4 PYROGEN TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE PYROGEN TESTING MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 PYROGEN TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of infectious diseases and increasing frequency of pandemics
5.2.1.2 Increasing R&D in the pharmaceutical & biotechnology industries
FIGURE 16 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017–2024
5.2.1.3 Growing focus on personalized medicine
TABLE 1 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008?2016
5.2.1.4 Growing awareness about food safety
FIGURE 17 NUMBER OF FOODBORNE DISEASE OUTBREAKS REPORTED TO ORU/NICD, SOUTH AFRICA, 2013-2017
5.2.1.5 High prevalence of chronic diseases
FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2017 VS. 2045 (MILLION CASES)
5.2.2 RESTRAINTS
5.2.2.1 High degree of consolidation
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing pharmaceutical outsourcing
5.2.3.2 Emerging markets offer lucrative opportunities
5.2.4 TRENDS
5.2.4.1 Shift from animal-based testing to in vitro testing
5.3 IMPACT OF COVID-19 ON THE PYROGEN TESTING MARKET
5.4 PRICING ANALYSIS
TABLE 2 PRICE OF PYROGEN TESTING PRODUCTS (2020)
5.5 VALUE CHAIN ANALYSIS
FIGURE 19 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 20 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.7 ECOSYSTEM ANALYSIS OF THE PYROGEN TESTING MARKET
FIGURE 21 ECOSYSTEM ANALYSIS OF THE PYROGEN TESTING MARKET
5.8 PORTER’S FIVE FORCES ANALYSIS
FIGURE 22 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
6 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 3 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 ASSAYS, KITS, & REAGENTS
6.2.1 REPEAT PURCHASES OF ASSAYS, KITS, & REAGENTS TO DRIVE THE MARKET GROWTH
TABLE 4 PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 NORTH AMERICA: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 EUROPE: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 ASIA PACIFIC: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 CONTINUOUS INNOVATION IN TECHNOLOGICALLY ADVANCED
PRODUCTS TO SUPPORT MARKET GROWTH
TABLE 8 PYROGEN TESTING INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 NORTH AMERICA: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 EUROPE: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 ASIA PACIFIC: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4 SERVICES
6.4.1 LACK OF EXPERTISE AND INFRASTRUCTURE FOR ANALYTICAL & QUALITY TESTING DRIVES RELIANCE ON SERVICE PROVIDERS
TABLE 12 PYROGEN TESTING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 EUROPE: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 ASIA PACIFIC: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7 PYROGEN TESTING MARKET, BY TEST TYPE
7.1 INTRODUCTION
TABLE 16 PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
7.2 LAL TESTS
TABLE 17 LAL TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.2.1 CHROMOGENIC TESTS
7.2.1.1 Ease of use & cost-effectiveness of chromogenic tests
to support market growth
TABLE 19 KEY PRODUCTS IN THE CHROMOGENIC TESTS MARKET, BY COMPANY
TABLE 20 CHROMOGENIC TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2 TURBIDIMETRIC TESTS
7.2.2.1 Higher precision of kinetic turbidimetric tests have
supported their adoption
TABLE 21 KEY PRODUCTS IN THE TURBIDIMETRIC TESTS MARKET, BY COMPANY
TABLE 22 TURBIDIMETRIC TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.3 GEL CLOT TESTS
7.2.3.1 Endotoxin determination with gel clot test method is simpler and more economical
TABLE 23 KEY PRODUCTS IN THE GEL CLOT TESTS MARKET, BY COMPANY
TABLE 24 GEL CLOT TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 IN VITRO TESTS
7.3.1 APPLICABILITY TO A GREATER VARIETY OF PRODUCTS IS DRIVING THE GROWTH OF THIS SEGMENT
TABLE 25 IN VITRO TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 RABBIT TESTS
7.4.1 INCREASING FOCUS ON THE USE OF NON-ANIMAL-BASED TESTING METHODS TO LIMIT MARKET GROWTH
TABLE 26 RABBIT TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
8 PYROGEN TESTING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 27 PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PYROGEN TESTING PRODUCTS
TABLE 28 PYROGEN TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
8.3 MEDICAL DEVICE COMPANIES
8.3.1 RISING NEED TO ENSURE THE SAFETY OF MANUFACTURED MEDICAL DEVICES HAS DRIVEN THE ADOPTION OF PYROGEN TESTING PRODUCTS
TABLE 29 PYROGEN TESTING MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2018–2025 (USD MILLION)
8.4 OTHER END USERS
TABLE 30 PYROGEN TESTING MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
9 PYROGEN TESTING MARKET, BY REGION
9.1 INTRODUCTION
TABLE 31 PYROGEN TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: PYROGEN TESTING MARKET SNAPSHOT
TABLE 32 NORTH AMERICA: PYROGEN TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American market
TABLE 37 US: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 38 US: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 39 US: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 US: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Support from government organizations is driving the growth of the pyrogen testing market in Canada
TABLE 41 CANADA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 42 CANADA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 43 CANADA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 CANADA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 45 EUROPE: PYROGEN TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 EUROPE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 47 EUROPE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany holds the largest share of the European market
TABLE 50 GERMANY: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 51 GERMANY: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 52 GERMANY: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 GERMANY: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.2 UK
9.3.2.1 Growth of the pharmaceutical & biotechnology industry to drive the market in the UK
TABLE 54 UK: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 55 UK: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 56 UK: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 UK: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing investments in life science R&D infrastructure development to support market growth
TABLE 58 FRANCE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 59 FRANCE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 60 FRANCE: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 FRANCE: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growth in this market is mainly driven by increasing life science R&D
TABLE 62 ITALY: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 63 ITALY: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 64 ITALY: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 ITALY: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing outsourcing of microbial testing services to fuel the adoption of pyrogen testing
TABLE 66 SPAIN: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 67 SPAIN: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 68 SPAIN: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 SPAIN: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 70 ROE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 71 ROE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 72 ROE: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 ROE: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: PYROGEN TESTING MARKET SNAPSHOT
TABLE 74 APAC: PYROGEN TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 APAC: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 76 APAC: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 77 APAC: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 APAC: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominates the market in the APAC
TABLE 79 CHINA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 80 CHINA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 81 CHINA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 CHINA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Expansion of pharmaceutical manufacturing plants in Japan to create market growth opportunities
TABLE 83 JAPAN: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 84 JAPAN: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 85 JAPAN: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 JAPAN: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 India’s growing contract research and manufacturing industry will favor the pyrogen testing market
TABLE 87 INDIA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 88 INDIA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 89 INDIA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 INDIA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 91 ROAPAC: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 92 ROAPAC: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 93 ROAPAC: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 ROAPAC: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 GROWING CONTRACT RESEARCH & MANUFACTURING ACTIVITIES TO SUPPORT THE MARKET GROWTH
TABLE 95 LATIN AMERICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 96 LATIN AMERICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 97 LATIN AMERICA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 LATIN AMERICA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
TABLE 99 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 100 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
FIGURE 25 KEY DEVELOPMENTS IN THE PYROGEN TESTING MARKET
10.2 MARKET SHARE ANALYSIS
FIGURE 26 PYROGEN TESTING MARKET SHARE, BY KEY PLAYER (2019)
10.3 COMPANY EVALUATION QUADRANT
10.3.1 VENDOR EXCLUSION CRITERIA
10.3.2 STARS
10.3.3 EMERGING LEADERS
10.3.4 PERVASIVE PLAYERS
10.3.5 PARTICIPANTS
FIGURE 27 PYROGEN TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
10.4 COMPETITIVE SCENARIO
10.4.1 PRODUCT LAUNCHES
TABLE 103 KEY PRODUCT LAUNCHES
10.4.2 ACQUISITIONS
TABLE 104 KEY ACQUISITIONS
10.4.3 EXPANSIONS
TABLE 105 KEY EXPANSIONS
10.4.4 AGREEMENTS
TABLE 106 KEY AGREEMENTS
10.4.5 PARTNERSHIPS
TABLE 107 KEY PARTNERSHIPS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1.1 CHARLES RIVER LABORATORIES, INC.
FIGURE 28 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
11.1.2 LONZA
FIGURE 29 LONZA: COMPANY SNAPSHOT (2019)
11.1.3 MERCK KGAA
FIGURE 30 MERCK KGAA: COMPANY SNAPSHOT (2019)
11.1.4 THERMO FISHER SCIENTIFIC, INC.
FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
11.1.5 ASSOCIATES OF CAPE COD, INC.
11.1.6 BIOM?RIEUX SA
FIGURE 32 BIOM?RIEUX SA: COMPANY SNAPSHOT (2019)
11.1.7 GENSCRIPT BIOTECH CORPORATION
FIGURE 33 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2019)
11.1.7.2 Products offered
11.1.8 EUROFINS SCIENTIFIC
FIGURE 34 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
11.1.9 WUXI APPTEC
FIGURE 35 WUXI APPTEC: COMPANY SNAPSHOT (2019)
11.1.10 STERIS PLC
FIGURE 36 STERIS PLC: COMPANY SNAPSHOT (2019)
11.2 OTHER PLAYERS
11.2.1 ELLAB A/S
11.2.2 FUJIFILM WAKO PURE CHEMICAL CORPORATION
11.2.3 INVIVOGEN
11.2.4 NELSON LABORATORIES, LLC
11.2.5 MICROCOAT BIOTECHNOLOGIE GMBH
11.2.6 HYCULT BIOTECH
11.2.7 ALMAC GROUP
11.2.8 PACIFIC BIOLABS
11.2.9 ACCUGEN LABORATORIES, INC.
11.2.10 TOXIKON
11.2.11 MINERVA ANALYTIX GMBH
11.2.12 INDOOR BIOTECHNOLOGIES, INC.
11.2.13 CREATIVE BIOARRAY
11.2.14 LUCIDEON LIMITED
11.2.15 NORTH AMERICAN SCIENCE ASSOCIATES, INC.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 PYROGEN TESTING MARKET
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 LIMITATIONS OF THE CURRENT EDITION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 PYROGEN TESTING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2.2.1 Key data from primary sources
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 PYROGEN TESTING MARKET: BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
FIGURE 5 PYROGEN TESTING MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 PYROGEN TESTING MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 PYROGEN TESTING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 PYROGEN TESTING MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 PYROGEN TESTING MARKET OVERVIEW
FIGURE 11 INCREASING R&D IN THE PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES IS DRIVING THE GROWTH OF THE PYROGEN TESTING MARKET
4.2 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 ASSAYS, KITS, & REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
4.3 PYROGEN TESTING MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST
END USERS OF PYROGEN TESTING PRODUCTS & SERVICES
4.4 PYROGEN TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE PYROGEN TESTING MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 PYROGEN TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of infectious diseases and increasing frequency of pandemics
5.2.1.2 Increasing R&D in the pharmaceutical & biotechnology industries
FIGURE 16 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017–2024
5.2.1.3 Growing focus on personalized medicine
TABLE 1 GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008?2016
5.2.1.4 Growing awareness about food safety
FIGURE 17 NUMBER OF FOODBORNE DISEASE OUTBREAKS REPORTED TO ORU/NICD, SOUTH AFRICA, 2013-2017
5.2.1.5 High prevalence of chronic diseases
FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2017 VS. 2045 (MILLION CASES)
5.2.2 RESTRAINTS
5.2.2.1 High degree of consolidation
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing pharmaceutical outsourcing
5.2.3.2 Emerging markets offer lucrative opportunities
5.2.4 TRENDS
5.2.4.1 Shift from animal-based testing to in vitro testing
5.3 IMPACT OF COVID-19 ON THE PYROGEN TESTING MARKET
5.4 PRICING ANALYSIS
TABLE 2 PRICE OF PYROGEN TESTING PRODUCTS (2020)
5.5 VALUE CHAIN ANALYSIS
FIGURE 19 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 20 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.7 ECOSYSTEM ANALYSIS OF THE PYROGEN TESTING MARKET
FIGURE 21 ECOSYSTEM ANALYSIS OF THE PYROGEN TESTING MARKET
5.8 PORTER’S FIVE FORCES ANALYSIS
FIGURE 22 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
6 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 3 PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 ASSAYS, KITS, & REAGENTS
6.2.1 REPEAT PURCHASES OF ASSAYS, KITS, & REAGENTS TO DRIVE THE MARKET GROWTH
TABLE 4 PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 NORTH AMERICA: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 EUROPE: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 ASIA PACIFIC: PYROGEN TESTING ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 CONTINUOUS INNOVATION IN TECHNOLOGICALLY ADVANCED
PRODUCTS TO SUPPORT MARKET GROWTH
TABLE 8 PYROGEN TESTING INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 NORTH AMERICA: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 EUROPE: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 ASIA PACIFIC: PYROGEN TESTING INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4 SERVICES
6.4.1 LACK OF EXPERTISE AND INFRASTRUCTURE FOR ANALYTICAL & QUALITY TESTING DRIVES RELIANCE ON SERVICE PROVIDERS
TABLE 12 PYROGEN TESTING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 EUROPE: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 ASIA PACIFIC: PYROGEN TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7 PYROGEN TESTING MARKET, BY TEST TYPE
7.1 INTRODUCTION
TABLE 16 PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
7.2 LAL TESTS
TABLE 17 LAL TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.2.1 CHROMOGENIC TESTS
7.2.1.1 Ease of use & cost-effectiveness of chromogenic tests
to support market growth
TABLE 19 KEY PRODUCTS IN THE CHROMOGENIC TESTS MARKET, BY COMPANY
TABLE 20 CHROMOGENIC TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.2 TURBIDIMETRIC TESTS
7.2.2.1 Higher precision of kinetic turbidimetric tests have
supported their adoption
TABLE 21 KEY PRODUCTS IN THE TURBIDIMETRIC TESTS MARKET, BY COMPANY
TABLE 22 TURBIDIMETRIC TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.2.3 GEL CLOT TESTS
7.2.3.1 Endotoxin determination with gel clot test method is simpler and more economical
TABLE 23 KEY PRODUCTS IN THE GEL CLOT TESTS MARKET, BY COMPANY
TABLE 24 GEL CLOT TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 IN VITRO TESTS
7.3.1 APPLICABILITY TO A GREATER VARIETY OF PRODUCTS IS DRIVING THE GROWTH OF THIS SEGMENT
TABLE 25 IN VITRO TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.4 RABBIT TESTS
7.4.1 INCREASING FOCUS ON THE USE OF NON-ANIMAL-BASED TESTING METHODS TO LIMIT MARKET GROWTH
TABLE 26 RABBIT TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
8 PYROGEN TESTING MARKET, BY END USER
8.1 INTRODUCTION
TABLE 27 PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PYROGEN TESTING PRODUCTS
TABLE 28 PYROGEN TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
8.3 MEDICAL DEVICE COMPANIES
8.3.1 RISING NEED TO ENSURE THE SAFETY OF MANUFACTURED MEDICAL DEVICES HAS DRIVEN THE ADOPTION OF PYROGEN TESTING PRODUCTS
TABLE 29 PYROGEN TESTING MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2018–2025 (USD MILLION)
8.4 OTHER END USERS
TABLE 30 PYROGEN TESTING MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
9 PYROGEN TESTING MARKET, BY REGION
9.1 INTRODUCTION
TABLE 31 PYROGEN TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: PYROGEN TESTING MARKET SNAPSHOT
TABLE 32 NORTH AMERICA: PYROGEN TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American market
TABLE 37 US: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 38 US: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 39 US: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 US: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Support from government organizations is driving the growth of the pyrogen testing market in Canada
TABLE 41 CANADA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 42 CANADA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 43 CANADA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 CANADA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 45 EUROPE: PYROGEN TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 EUROPE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 47 EUROPE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany holds the largest share of the European market
TABLE 50 GERMANY: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 51 GERMANY: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 52 GERMANY: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 GERMANY: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.2 UK
9.3.2.1 Growth of the pharmaceutical & biotechnology industry to drive the market in the UK
TABLE 54 UK: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 55 UK: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 56 UK: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 UK: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing investments in life science R&D infrastructure development to support market growth
TABLE 58 FRANCE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 59 FRANCE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 60 FRANCE: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 FRANCE: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growth in this market is mainly driven by increasing life science R&D
TABLE 62 ITALY: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 63 ITALY: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 64 ITALY: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 ITALY: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing outsourcing of microbial testing services to fuel the adoption of pyrogen testing
TABLE 66 SPAIN: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 67 SPAIN: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 68 SPAIN: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 SPAIN: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 70 ROE: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 71 ROE: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 72 ROE: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 ROE: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: PYROGEN TESTING MARKET SNAPSHOT
TABLE 74 APAC: PYROGEN TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 APAC: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 76 APAC: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 77 APAC: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 APAC: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominates the market in the APAC
TABLE 79 CHINA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 80 CHINA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 81 CHINA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 CHINA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Expansion of pharmaceutical manufacturing plants in Japan to create market growth opportunities
TABLE 83 JAPAN: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 84 JAPAN: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 85 JAPAN: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 JAPAN: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 India’s growing contract research and manufacturing industry will favor the pyrogen testing market
TABLE 87 INDIA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 88 INDIA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 89 INDIA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 INDIA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 91 ROAPAC: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 92 ROAPAC: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 93 ROAPAC: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 ROAPAC: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 GROWING CONTRACT RESEARCH & MANUFACTURING ACTIVITIES TO SUPPORT THE MARKET GROWTH
TABLE 95 LATIN AMERICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 96 LATIN AMERICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 97 LATIN AMERICA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 LATIN AMERICA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
TABLE 99 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 100 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA: LAL TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: PYROGEN TESTING MARKET, BY END USER, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
FIGURE 25 KEY DEVELOPMENTS IN THE PYROGEN TESTING MARKET
10.2 MARKET SHARE ANALYSIS
FIGURE 26 PYROGEN TESTING MARKET SHARE, BY KEY PLAYER (2019)
10.3 COMPANY EVALUATION QUADRANT
10.3.1 VENDOR EXCLUSION CRITERIA
10.3.2 STARS
10.3.3 EMERGING LEADERS
10.3.4 PERVASIVE PLAYERS
10.3.5 PARTICIPANTS
FIGURE 27 PYROGEN TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
10.4 COMPETITIVE SCENARIO
10.4.1 PRODUCT LAUNCHES
TABLE 103 KEY PRODUCT LAUNCHES
10.4.2 ACQUISITIONS
TABLE 104 KEY ACQUISITIONS
10.4.3 EXPANSIONS
TABLE 105 KEY EXPANSIONS
10.4.4 AGREEMENTS
TABLE 106 KEY AGREEMENTS
10.4.5 PARTNERSHIPS
TABLE 107 KEY PARTNERSHIPS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1.1 CHARLES RIVER LABORATORIES, INC.
FIGURE 28 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
11.1.2 LONZA
FIGURE 29 LONZA: COMPANY SNAPSHOT (2019)
11.1.3 MERCK KGAA
FIGURE 30 MERCK KGAA: COMPANY SNAPSHOT (2019)
11.1.4 THERMO FISHER SCIENTIFIC, INC.
FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
11.1.5 ASSOCIATES OF CAPE COD, INC.
11.1.6 BIOM?RIEUX SA
FIGURE 32 BIOM?RIEUX SA: COMPANY SNAPSHOT (2019)
11.1.7 GENSCRIPT BIOTECH CORPORATION
FIGURE 33 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2019)
11.1.7.2 Products offered
11.1.8 EUROFINS SCIENTIFIC
FIGURE 34 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
11.1.9 WUXI APPTEC
FIGURE 35 WUXI APPTEC: COMPANY SNAPSHOT (2019)
11.1.10 STERIS PLC
FIGURE 36 STERIS PLC: COMPANY SNAPSHOT (2019)
11.2 OTHER PLAYERS
11.2.1 ELLAB A/S
11.2.2 FUJIFILM WAKO PURE CHEMICAL CORPORATION
11.2.3 INVIVOGEN
11.2.4 NELSON LABORATORIES, LLC
11.2.5 MICROCOAT BIOTECHNOLOGIE GMBH
11.2.6 HYCULT BIOTECH
11.2.7 ALMAC GROUP
11.2.8 PACIFIC BIOLABS
11.2.9 ACCUGEN LABORATORIES, INC.
11.2.10 TOXIKON
11.2.11 MINERVA ANALYTIX GMBH
11.2.12 INDOOR BIOTECHNOLOGIES, INC.
11.2.13 CREATIVE BIOARRAY
11.2.14 LUCIDEON LIMITED
11.2.15 NORTH AMERICAN SCIENCE ASSOCIATES, INC.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
